Mersana Therapeutics Inc (MRSN)
2.77
+0.04
(+1.47%)
USD |
NASDAQ |
May 20, 16:00
2.77
0.00 (0.00%)
Pre-Market: 09:18
Mersana Therapeutics Cash from Investing (Quarterly): -72.55M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -72.55M |
| December 31, 2023 | 20.15M |
| September 30, 2023 | 103.78M |
| June 30, 2023 | -5.439M |
| March 31, 2023 | 1.396M |
| December 31, 2022 | -45.43M |
| September 30, 2022 | -16.49M |
| June 30, 2022 | -90.47M |
| March 31, 2022 | -0.329M |
| December 31, 2021 | -0.155M |
| September 30, 2021 | -0.046M |
| June 30, 2021 | -0.333M |
| March 31, 2021 | -0.114M |
| December 31, 2020 | -0.188M |
| September 30, 2020 | 2.805M |
| June 30, 2020 | 14.98M |
| March 31, 2020 | 19.44M |
| Date | Value |
|---|---|
| December 31, 2019 | 16.50M |
| September 30, 2019 | -41.77M |
| June 30, 2019 | -12.15M |
| March 31, 2019 | 10.13M |
| December 31, 2018 | 13.72M |
| September 30, 2018 | 20.73M |
| June 30, 2018 | 29.85M |
| March 31, 2018 | 22.90M |
| December 31, 2017 | -13.19M |
| September 30, 2017 | -41.85M |
| June 30, 2017 | -44.11M |
| March 31, 2017 | -0.471M |
| December 31, 2016 | 0.254M |
| September 30, 2016 | -0.06M |
| June 30, 2016 | -0.883M |
| March 31, 2016 | -0.395M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-90.47M
Minimum
Jun 2022
103.78M
Maximum
Sep 2023
-5.321M
Average
-0.1715M
Median
Cash from Investing (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 7.537M |
| Geron Corp | 34.21M |
| Insmed Inc | 295.32M |
| Altimmune Inc | -39.52M |
| InfuSystems Holdings Inc | -0.418M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -32.66M |
| Cash from Financing (Quarterly) | 5.829M |
| Free Cash Flow | -173.92M |
| Free Cash Flow Per Share (Quarterly) | -0.27 |
| Free Cash Flow to Equity (Quarterly) | -32.86M |
| Free Cash Flow Yield | -52.52% |